Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
European Journal of Pharmacology|October 18, 2023
Promising drug candidates for the treatment of polycystic ovary syndrome (PCOS) as alternatives to the classical medication metforminHanan S Anbar, Nisha Yarifbhai Vahora, Hajra Laghman Shah, et al.
Molecules (Basel, Switzerland)|December 10, 2021
A Review of HER4 (ErbB4) Kinase, Its Impact on Cancer, and Its InhibitorsMohammed I El-Gamal, Nada H Mewafi, Nada E Abdelmotteleb, et al.
European Journal of Medicinal Chemistry|July 8, 2021
Discovery of first-in-class imidazothiazole-based potent and selective ErbB4 (HER4) kinase inhibitorsSeyed-Omar Zaraei, Rawan M Sbenati, Nour N Alach, et al.
Antibiotics (Basel, Switzerland)|March 29, 2023
Novel Anti-Acanthamoebic Activities of Irosustat and STX140 and Their NanoformulationsRuqaiyyah Siddiqui, Mutasem Rawas-Qalaji, Mohammed I El-Gamal, et al.
Plos One|September 23, 2024
The wound healing and hypoglycemic activates of date palm (Phoenix dactylifera) leaf extract and saponins in diabetic and normal ratsHanan S Anbar, Naglaa Gamil Shehab, Ayah Yasin, et al.
Gut Pathogens|March 4, 2026
Novel indole-based sulfonate and sulfamate derivatives as potent and selective urease inhibitors targeting Helicobacter pylori: a promising therapeutic strategyGhalia Khoder, Esra M Mustafa, Sumera Zaib, et al.
Life Sciences|June 7, 2025
Protective potential of Irosustat, STX140 and the sulfonate derivative 1G in counteracting cisplatin-induced renal and hepatic toxicities: An in vivo comparative studyHanan S Anbar, Aseel W Radi, Haidi A Shaker, et al.
Bioorganic & Medicinal Chemistry Letters|January 26, 2013
Discovery of olmesartan hexetil: a new potential prodrug of olmesartanMohammed I El-Gamal, Hanan S Anbar, Hye Jin Chung, et al.
Bioorganic & Medicinal Chemistry|June 28, 2022
Design, synthesis, and biological evaluation of a new series of pyrazole derivatives: Discovery of potent and selective JNK3 kinase inhibitorsReinad R Abu Rabah, Anusha Sebastian, Srinivasulu Vunnam, et al.
European Journal of Medicinal Chemistry|December 14, 2020
Design, synthesis, biological evaluation, and modeling studies of novel conformationally-restricted analogues of sorafenib as selective kinase-inhibitory antiproliferative agents against hepatocellular carcinoma cellsRawan M Sbenati, Seyed-Omar Zaraei, Mohammed I El-Gamal, et al.
Pageof 7